Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation. (Record no. 27831435)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01384 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517185838.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201808s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1618-7601 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s10198-017-0942-2 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jacobs, Maartje S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180827 |
245 00 - TITLE STATEMENT | |
Title | Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The European journal of health economics : HEPAC : health economics in prevention and care |
Date of publication, distribution, etc. | Sep 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 957-965 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Atrial Fibrillation |
General subdivision | therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cost-Benefit Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Electric Countershock |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Factor Xa Inhibitors |
General subdivision | economics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Netherlands |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quality of Life |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quality-Adjusted Life Years |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rivaroxaban |
General subdivision | economics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stroke |
General subdivision | prevention & control |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Jong, Lisa A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Postma, Maarten J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tieleman, Robert G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Hulst, Marinus |
773 0# - HOST ITEM ENTRY | |
Title | The European journal of health economics : HEPAC : health economics in prevention and care |
Related parts | vol. 19 |
-- | no. 7 |
-- | p. 957-965 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10198-017-0942-2">https://doi.org/10.1007/s10198-017-0942-2</a> |
Public note | Available from publisher's website |
No items available.